Login / Signup

Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis.

Bernard SurialDominik WyserCharles BéguelinAdrià Ramírez-MenaAndri RauchGilles Wandeler
Published in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Depending on the setting, between 4% and 13% of HBV-infected individuals in SSA have cirrhosis and need immediate antiviral therapy. These estimates should be considered when planning HBV treatment strategies and resource allocation.
Keyphrases
  • hepatitis b virus
  • liver failure
  • risk factors
  • stem cells
  • mesenchymal stem cells
  • cell therapy